Magnetecs has sold its Robotic Catheter Guidance Control and Imaging system (CGCI) to the Yonsei University Severance Hospital located in South Korea. This is the first sale of the CGCI system in Asia. The installation will be completed by the fourth quarter of 2011.
A series of clinical trials will be conducted with the CGCI system at the hospital for mapping and ablation procedures that are performed on patients who have arrhythmia. The results of these trials will be used for submitting the report to the Korean Food and Drug Administration on the robotic CGCI system.
The robotic guidance system was previously installed at the Hospital Universitario in Spain, at which the first phase of clinical trials on patients with arrhythmia was completed. During these trials a detailed map of the heart was created with the help of the CGCI system. The main result of the study is a measurement of target acquisition of the intra-cardiac anatomic site and the repetition of the acquisition. Magnetecs has also got into an agreement with the Mount Sinai medical center in New York for installing the CGCI by the year 2012. It has planned several other installations in Europe, US, Israel and Asia. The CEO of Magnetecs considered such installations as a measure of the efficiency and safety of the CGCI system. The chief medical officer at Magnetecs mentioned that they had plans of conducting exhaustive clinical trials at several locations spread across US, Europe and Canada. He added that by increasing the number of installation sited of CGCI, Magnetecs will be in a position to commercialise the technology so that it reaches arrhythmia patients across the world.
Source: http://www.magnetecs.com/